Abstract
Contraception stands as the fulcrum of a delicate balance between the reproductive experience and sexuality/genitality as an end in itself, giving the latter a playful and recreational dimension. Hormonal contraception can act on sexuality through the steroid components, their quantity, formulation, route of administration, and the regimen used; each of these variables is capable of modulating both the somatic-functional system and the psycho-relational and sexual areas.
The relationship between contraception and sexuality depends on complex individual, biological, psychological, and couple motivational variables; such a statement introduces the real tailoring concept, in short, the identification of a contraceptive suitable for “that woman” and “that couple.” Finally, the acceptability of a contraceptive method depends not only on its tolerability and metabolic neutrality, but also on the impact that the method can have on sexuality and quality of life. Contraceptive counseling must necessarily take into account these important elements, since the success of a contraceptive choice is closely connected to the influence that the method will have on sexuality.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sonfield A, Hasstedt K, Kavanaugh ML, Anderson R. The social and economic benefits of women’s ability to determine whether and when to have children. New York: Guttmacher Institute; 2013.
Elaut E, Buysse A, De Sutter P, Gerris J, De Cuypere G, T’Sjoen G. Cycle-related changes in mood, sexual desire, and sexual activity in oral contraception-using and nonhormonal-contraception-using couples. J Sex Res. 2016;53:125–36.
Caruso S, Agnello C, Malandrino C, Lo Presti L, Cicero C, Cianci S. Do hormones influence women’s sex? Sexual activity over the menstrual cycle. J Sex Med. 2014;11:211–21.
Miller GF. The mating mind: how sexual choice shaped the evolution of human nature. New York: Anchor Books; 2000.
Gangestad SW, Thornhill R. Human oestrus. Proc Biol Sci. 2008;275:991–1000.
Roney JR, Simmons ZL. Hormonal predictors of sexual motivation in natural menstrual cycles. Horm Behav. 2013;63:636–45.
Bullivant SB, Sellergren SA, Stern K, Spencer NA, Jacob S, Menella JA, et al. Women’s sexual experience during the menstrual cycle: Identification of the sexual phase by non-invasive measurement of luteinizing hormone. J Sex Res. 2004;41:82–93.
Wilcox AJ, Baird DD, Dunson DB, McConnaughey DR, Kesner JS, Weinberg CR. On the frequency of intercourse around ovulation: Evidence for biological influences. Hum Reprod. 2004;19:1539–43.
Gildersleeve K, Haselton MG, Fales MR. Do women’s mate preferences change across the ovulatory cycle? A meta-analytic review. Psychol Bull. 2014;140:1205–59.
Brewis A, Meyer M. Demographic evidence that human ovulation is undetectable (at least in pair bonds). Curr Anthropol. 2005;46:465–71.
Dobbins JG. Implication of a time-dependent model of sexual intercourse within the menstrual cycle. J Biosoc Sci. 1980;12:133–40.
Harris AL, Vitzthum VJ. Darwin’s legacy: an evolutionary view of women’s reproductive and sexual functioning. J Sex Res. 2013;50:207–46.
Grimes DA, Schulz KF. Nonspecific side effects of oral contraceptives: nocebo or noise? Contraception. 2011;83:5–9.
Tone A. Devices and desires: a history of contraceptives in America. New York: Hill and Wang; 2001.
Watkins ES. On the pill: A social history of oral contraceptives, 1950–1970. Baltimore: Johns Hopkins University Press; 1998.
Burrows LJ, Basha M, Goldstein AT. The effects of hormonal contraceptives on female sexuality: a review. J Sex Med. 2012;9:2213–23.
De Castro Coelho F, Barros C. The potential of hormonal contraception to influence female sexuality. Int J Reprod Med. 2019;2019:9701384.
Gabalci E, Terzioglu F. The effect of family planning methods used by women of reproductive age on their sexual life. Sex Disabil. 2010;28:275–85.
Graham CA, Bancroft J, Doll HA, Greco T, Tanner A. Does oral contraceptive-induced reduction in free testosterone adversely affect the sexuality or mood of women? Psychoneuroendocrinology. 2007;32:246–55.
Casey PM, MacLaughlin KL, Faubion SS. Impact of contraception on female sexual function. J Women’s Health (Larchmt). 2017;26:207–13.
Bancroft J, Davidson DW, Warner P, Tyrer G. Androgens and sexual behaviour in women using oral contraceptives. Clin Endocrinol. 1980;12:327–40.
Pastor Z, Holla K, Chmel R. The influence of combined oral contraceptives on female sexual desire: a systematic review. Eur J Contracept Reprod Health Care. 2013;18:27–43.
Smith NK, Jozkowski KN, Sanders SA. Hormonal contraception and female pain, orgasm and sexual pleasure. J Sex Med. 2014;11:462–70.
Wallwiener CW, Wallwiener LM, Seeger H, Schönfisch B, Mueck AO, Bitzer J, et al. Are hormonal components of oral contraceptives associated with impaired female sexual function? A questionnaire-based online survey of medical students in Germany, Austria, and Switzerland. Arch Gynecol Obstet. 2015;292:883–90.
Caruso S, Malandrino C, Cicero C, Ciancio F, Cariola M, Cianci A. Quality of sexual life of women on oral contraceptive continued-regimen: pilot study. J Sex Med. 2013;10:460–6.
Burrows LJ, Goldstein AT. The treatment of vestibulodynia with topical estradiol and testosterone. Sex Med. 2013;1:30–3.
Davis SR. Should women receive androgen replacement therapy, and if so, how? Clin Endocrinol. 2010;72:149–54.
Caruso S, Agnello C, Romano M, Cianci S, Lo Presti L, Malandrino C, Cianci A. Preliminary study on the effect of four phasic estradiol valerate and dienogest (E2V/DNG) oral contraceptive on the quality of sexual life. J Sex Med. 2011;8:2841–50.
Bancroft J, Hammond G, Graham C. Do oral contraceptives produce irreversible effects on women’s sexuality? J Sex Med. 2006;3:567; author reply, 568–570.
Guzick DS, Huang L-S, Broadman BA, Nealon M, Hornstein MD. Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis-associated pelvic pain. Fertil Steril. 2011;95:1568–73.
Caruso S, Rugolo S, Agnello C, Romano M, Cianci A. Quality of sexual life in hyperandrogenic women treated with an oral contraceptive containing chlormadinone acetate. J Sex Med. 2009;6:3376–84.
Graham CA, Sanders SA, Milhausen RR. McBride KR. Turning on and turning off: A focus group study of the factors that affect women’s sexual arousal. Arch Sex Behav. 2004;33:527–38.
Benson Gold R. Rekindling efforts to prevent unplanned pregnancy: a matter of “equity and common sense”. Guttmacher Policy Rev. 2006;9:2–6.
Rosenberg MJ, Meyers A, Roy V. Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations. Contraception. 1999;60:321–9.
Caruso S, Agnello C, Intelisano G, Farina M, Di Mari L, Cianci A. Sexual behavior of women taking low-dose oral contraceptive containing 15 microg ethinylestradiol/60 microg gestodene. Contraception. 2004;69:237–40.
Coenen CMH, Thomas CMG, Borm GF, Hollanders JMG, Rollands R. Changes in androgens during treatment with four low-dose contraceptives. Contraception. 1996;53:171–6.
Greco T, Graham CA, Bancroft J, Tanner A, Doll HA. The effects of oral contraceptives on androgen levels and their relevance to premenstrual mood and sexual interest: A comparison of two triphasic formulations containing norgestimate and either 35 or 25 microg of ethinyl estradiol. Contraception. 2007;76:8–17.
Sanders SA, Graham CA, Bass JL, Bancroft J. A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception. 2001;64:51–8.
Schaffir J. Hormonal contraception and sexual desire: a critical review. J Sex Marital Ther. 2006;32:305–14.
Wiebe ER, Brotto LA, MacKay J. Characteristics of women who experience mood and sexual side effects with use of hormonal contraception. J Obstet Gynaecol Can. 2011;33:1234–40.
Sabatini R, Cagiano R. Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. Contraception. 2006;74:220–3.
Caruso S, Panella M, Giunta G, Matarazzo MG, Cianci A. Comparative randomized study on the sexual function and quality of life of women on contraceptive vaginal ring containing ethinylestradiol/etonogestrel 3.47/11.00mg or 2.7/11.7mg. Gynecol Endocrinol. 2019;16:1–5.
Novák A, de la Loge C, Abetz L, van der Meulen EA. The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability. Contraception. 2003;67:187–94.
Timmer CJ, Mulders TM. Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring. Clin Pharmacokinet. 2000;39:233–42.
Gracia CR, Sammel MD, Charlesworth S, Lin H, Barnhart KT, Creinin MD. Sexual function in first-time contraceptive ring and contraceptive patch users. Fertil Steril. 2010;93:21–8.
Veres S, Miller L, Burington B. A comparison between the vaginal ring and oral contraceptives. Obstet Gynecol. 2004;104:555–63.
Lete I, Cuesta MC, Marín JM, Guerra S. Vaginal health in contraceptive vaginal ring users—a review. Eur J Contracept Reprod Health Care. 2013;18:234–41.
Guida M, Di Spiezio Sardo A, Bramante S, Sparice S, Acunzo G, Tommaselli GA, et al. Effects of two types of hormonal contraception—oral versus intravaginal—on the sexual life of women and their partners. Hum Reprod. 2005;20:1100–6.
Elaut E, Buysse A, De Sutter P, De Cuypere G, Gerris J, Deschepper E, et al. Relation of androgen receptor sensitivity and mood to sexual desire in hormonal contraception users. Contraception. 2012;85:470–9.
Caruso S, Cianci S, Malandrino C, Cicero C, Lo Presti L, Cianci A. Quality of sexual life of women using the contraceptive vaginal ring in extended cycles: preliminary report. Eur J Contracept Reprod Health Care. 2014;19:307–14.
Mohamed AM, El-Sherbiny WS, Mostafa WA. Combined contraceptive ring versus combined oral contraceptive (30-𝜇g ethinylestradiol and 3-mg drospirenone). Int J Gynecol Obstet. 2011;114:145–8.
WHO. WHO medical eligibility criteria for contraceptive use. 4th ed. Geneva: WHO; 2009. http://www.who.int/reproductivehealth/publications/family_planning/9789241563888/en/index.html.
Graham CA, Ramos R, Bancroft J, Maglaya C, Farley TMM. The effects of steroidal contraceptives on the well-being and sexuality of women: a double-blind, placebo-controlled, two-centre study of combined and progestogen-only methods. Contraception. 1995;52:363–9.
McCoy NL, Matyas JR. Oral contraceptives and sexuality in university women. Arch Sex Behav. 1996;25:73–90.
Jung-Hoffman C, Kuhl H. Divergent effects of two low-dose oral contraceptives on sex hormone-binding globulin and free testosterone. Am J Obstet Gynecol. 1987;156:199–203.
Bitzer J, Tschudin S, Meier-Burgoa J, Armbruster U, Schwendke A. Effects on the quality of life of a new oral contraceptive containing 30 mcg EE and 3 mg drospirenone (Yasmin). Praxis (Bern 1994). 2003;92:1177–84.
Secura GM, Allsworth JE, Madden T, Mullersman JL, Peipert JF. The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception. Am J Obstet Gynecol. 2010;203:115.e1–7.
Rose SB, Lawton BA. Impact of long-acting reversible contraception on return for repeat abortion. Am J Obstet Gynecol. 2012;206:37.e1–6.
Cristobal I, Neyro J-L, Lete I. The new LNG-releasing IUS: a new opportunity to reduce the burden of unintended pregnancy. Eur J Obstet Gynecol Reprod Biol. 2015;90:58–64.
Grunloh DS, Casner T, Secura GM, Peipert JF, Madden T. Characteristics associated with discontinuation of long-acting reversible contraception within the first 6 months of use. Obstet Gynecol. 2013;122:1214–21.
Sanders JN, Higgins JA, Adkins DE, Stoddard GJ, Gawron LM, Turok DK. The impact of sexual satisfaction, functioning, and perceived contraceptive effects on sex life on IUD and implant continuation at 1 year. Womens Health Issues. 2018;28:401–7.
Gomez AM, Clark JB. The relationship between contraceptive features preferred by young women and interest in IUDs: an exploratory analysis. Perspect Sex Reprod Health. 2014;46:157–63.
Caruso S, Cianci S, Vitale SG, Fava V, Cutello S, Cianci A. Sexual function and quality of life of women adopting the levonorgestrel-releasing intrauterine system (LNG-IUS 13.5 mg) after abortion for unintended pregnancy. Eur J Contracept Reprod Health Care. 2018;23:24–31.
Neri M, Piras B, Paoletti AM, Piras B, Vallerino V, Corda V, Ronchetti C, Taccori V, Pilloni M, Zedda P, Capobianco G, Dessole S, Melis GB, Mais V. Long-acting reversible contraception (LARC) with the intrauterine system with levonorgestrel (6mcg/d): observational study on the acceptability, quality of life, and sexuality in Italian women. Gynecol Endocrinol. 2018;34:532–5.
Higgins JA, Ryder K, Skarda G, Koepsel E, Bennett EA. The sexual acceptability of intrauterine contraception: a qualitative study of young adult women. Perspect Sex Reprod Health. 2015;47:115–22.
Tazegül Pekin A, Seçilmiş Kerimoğlu O, Kebapcılar AG, Yılmaz SA, Benzer N, Celik C. Depressive symptomatology and quality of life assessment among women using the levonorgestrel-releasing intrauterine system: an observational study. Arch Gynecol Obstet. 2014;290:507–11.
Higgins JA, Smith NK. The sexual acceptability of contraception: reviewing the literature and building a new concept. J Sex Res. 2016;53:417–56.
Blumenthal PD, Gemzell-Danielsson K, Marintcheva-Petrova M. Tolerability and clinical safety of Implanon. Eur J Contracept Reprod Health Care. 2008;13:29–36.
Apter D. Contraception options: aspects unique to adolescent and young adult. Best Pract Res Clin Obstet Gynaecol. 2018;48:115–27.
Walsh-Buhi ER. Helmy HL. Trends in long-acting reversible contraceptive (LARC) use, LARC use predictors, and dual-method use among a national sample of college women. J Am Coll Heal. 2018;66:225–36.
Di Carlo C, Sansone A, De Rosa N, Gargano V, Tommaselli GA, Nappi C, Bifulco G. Impact of an implantable steroid contraceptive (etonogestrel-releasing implant) on quality of life and sexual function: a preliminary study. Gynecol Endocrinol. 2014;30:53–6.
Guida M, Farris M, Aquino CI, Rosato E, Cipullo LMA, Bastianelli C. Nexplanon subdermal implant: assessment of sexual profile, metabolism, and bleeding in a cohort of Italian women. Biomed Res Int. 2019;2019:3726957.
Guida M, Di Carlo C, Troisi J, Gallo A, Cibarelli F, Martini E, Tiranini L, Nappi RE. The sexuological impact of hormonal contraceptives based on their route of administration. Gynecol Endocrinol. 2017;33:218–22.
Higgins JA, Hoffman S, Graham CA, Sanders SA. Relationships between condoms, hormonal methods, and sexual pleasure and satisfaction: an exploratory analysis from the Women’s Well-Being and Sexuality Study. Sex Health. 2008;5:321–30.
Higgins JA, Hirsch JS. Pleasure and power: incorporating sexuality, agency, and inequality into research on contraceptive use and unintended pregnancy. Am J Public Health. 2008;98:1803–13.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Caruso, S., Fava, V., Rapisarda, A.M.C. (2021). Contraception and Sexuality. In: Meriggiola, M.C., Gemzell-Danielsson, K. (eds) Female and Male Contraception. Trends in Andrology and Sexual Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-70932-7_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-70932-7_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-70931-0
Online ISBN: 978-3-030-70932-7
eBook Packages: MedicineMedicine (R0)